ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 285,621 | 262,646 | 217,833 | 149,836 | 144,894 |
| Marketable Securities | 9,131 | 8,859 | 5,718 | 5,386 | 6,307 |
| Receivables | 281,082 | 252,617 | 225,654 | 220,334 | 221,726 |
| Inventories | 143,067 | 146,475 | 138,315 | 137,408 | 136,782 |
| TOTAL | $753,117 | $698,402 | $602,630 | $536,290 | $528,456 |
| Non-Current Assets | |||||
| PPE Net | 62,476 | 63,560 | 59,247 | 58,179 | 56,863 |
| Intangibles | 542,006 | 562,297 | 580,853 | 599,157 | 601,824 |
| Other Non-Current Assets | 82,778 | 83,893 | 100,271 | 98,802 | 97,326 |
| TOTAL | $687,260 | $709,750 | $740,371 | $756,138 | $756,013 |
| Total Assets | $1,440,377 | $1,408,152 | $1,343,001 | $1,292,428 | $1,284,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,268 | 15,241 | 13,216 | 11,193 | 9,172 |
| Accounts payable and accrued liabilities | 62,583 | 69,795 | 54,569 | 53,058 | 45,656 |
| Accrued Expenses | 195,855 | 185,456 | 165,273 | 123,147 | 132,074 |
| Other current liabilities | 167 | 63 | 483 | 229 | 29 |
| TOTAL | $278,112 | $270,555 | $236,835 | $201,815 | $194,452 |
| Non-Current Liabilities | |||||
| Long Term Debt | 291,840 | 297,677 | 301,484 | 305,294 | 309,108 |
| Other Non-Current Liabilities | 329,701 | 334,103 | 343,075 | 341,849 | 352,379 |
| TOTAL | $621,541 | $631,780 | $644,559 | $647,143 | $661,487 |
| Total Liabilities | $899,653 | $902,335 | $881,394 | $848,958 | $855,939 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,425 | 22,469 | 21,700 | 21,662 | 21,774 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -23,099 | -50,589 | -76,862 | -85,004 | -100,279 |
| Other shareholders' equity | 784 | 3,173 | 28,568 | 28,417 | 30,154 |
| TOTAL | $540,724 | $505,817 | $461,607 | $443,470 | $428,530 |
| Total Liabilities And Equity | $1,440,377 | $1,408,152 | $1,343,001 | $1,292,428 | $1,284,469 |